Recently, YZPC won new drug certificate for Doxycycline Hydrochloride Granules issued by the Ministry of Agriculture of China

Doxycycline hydrochloride is the second generation of semisynthetic tetracycline derivatives, it has broad antibacterial spectrum and strong antibacterial activity, it is a new dosage form of doxycycline which is independently developed byYZPC.

Compared with the existing dosage forms of doxycycline hydrochloride, it has following advantages:

1) New indication was added. This product can also be used for the treatment of porcine respiratory diseases caused by actinobacillus pleuropneumoniae sensitive to doxycycline;

2) Short withdrawal time. Process optimization was applied in order to shorten the withdrawal time and conducive to the clinical-scientific application of this product;

3) Well-dissolved. Improved solubility can avoid water turbidity during the use of soluble powder caused by undissolved powder and further more avoid the blockage of drinking water pipeline and other problems.

4) Granules avoid many disadvantages, like dispersion, adsorption, aggregation and moisture etc. Thus, the product has the good stability, protect personnel contact with the drug from the medicine dust.

The successful declaration of this product will help optimize the industrial structure of veterinary drug products in China, further meet the market demand, and enhance the market competitiveness of YZPC.